Leuprolide Acetate Kit
Product Images NDC 55150-478

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 55150-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Leuprolide Fig1)

Figure A (Leuprolide Fig1)
FDA Label Image

Figure J (Leuprolide Fig10)

Figure J (Leuprolide Fig10)
FDA Label Image

Figure K (Leuprolide Fig11)

Figure K (Leuprolide Fig11)
FDA Label Image

Figure L (Leuprolide Fig12)

Figure L (Leuprolide Fig12)
FDA Label Image

Leuprolide-figure-13 (Leuprolide Fig13)

Leuprolide-figure-13 (Leuprolide Fig13)
This is a description of a medication called Leuprolide Acetate Injection made by AuroMedics Pharma LLC. The usual dosage is 0.2 mL (1 mg) administered subcutaneously once daily, and it is recommended to check the package insert for further instructions. The medication should be stored below 5°C (77°F) and protected from light, and it is available in a sterile 2.8 mL multiple-dose vial containing 14 mg per vial.*
FDA Label Image

Leuprolide-figure-14 (Leuprolide Fig14)

Leuprolide-figure-14 (Leuprolide Fig14)
FDA Label Image

Package Label-principal Display Panel-14 mg Per 2.8 mL (1 mg/0.2 mL) (Container-Carton (14 Days Kit))

Package Label-principal Display Panel-14 mg Per 2.8 mL (1 mg/0.2 mL) (Container-Carton (14 Days Kit))
This appears to be a mixture of different types of text. Some of the text references a drug called Leuprolide Acetate Injection, including dosage information and prescribing information. There are also some seemingly random combinations of letters and numbers, as well as a few instances of what may be distorted words or phrases. Without further context, it is difficult to provide a more specific description.*
FDA Label Image

Figure B (Leuprolide Fig2)

Figure B (Leuprolide Fig2)
FDA Label Image

Figure C (Leuprolide Fig3)

Figure C (Leuprolide Fig3)
FDA Label Image

Figure D (Leuprolide Fig4)

Figure D (Leuprolide Fig4)
FDA Label Image

Figure E (Leuprolide Fig5)

Figure E (Leuprolide Fig5)
FDA Label Image

Figure F (Leuprolide Fig6)

Figure F (Leuprolide Fig6)
FDA Label Image

Figure G (Leuprolide Fig7)

Figure G (Leuprolide Fig7)
FDA Label Image

Figure H (Leuprolide Fig8)

Figure H (Leuprolide Fig8)
FDA Label Image

Figure I (Leuprolide Fig9)

Figure I (Leuprolide Fig9)
FDA Label Image

Chemical Structure (Leuprolide Str)

Chemical Structure (Leuprolide Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.